Search for Clinical Trial Results

Sponsored By

Fournier Gangrene - 7 Studies Found

Status Study
Recruiting Study Name: Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections
Condition:
  • Necrotizing Soft Tissue Infections
  • Necrotizing Fasciitis
  • <
    Date: 2015-06-06
    Interventions:
    • Drug: AB103 0.5 mg/kg Other Na
Completed Study Name: Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections
Condition:
  • Fasciitis, Necrotizing
  • Severe Necrotizing Skin and Soft Tissue Infections
  • Necrotizing Soft Tissue Infection
  • Necrotizing Fasciitis
  • Ga
    Date: 2015-07-03
Recruiting Study Name: Prognosis and Treatment of Necrotizing Soft Tissue Infections: A Prospective Cohort Study
Condition:
  • Necrotizing Soft Tissue Infection
  • Necrotizing Fascitis
  • Gas
    Date: 2017-04-26
    Interventions: Device: Hyperbaric oxygen therapy Hyperbaric oxygen therapy with 100 % oxygen at 1.8 ATA for 2 hours.
Completed Study Name: Biomarkers in Patients With Flesh-eating Bacterial Infections
Condition:
  • Necrotizing Soft Tissue Infection
  • Necrotizing Fasciitis
  • Ga
    Date: 2014-06-29
Completed Study Name: Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial
Condition:
  • Necrotizing Soft Tissue Infection
  • Necrotizing Fasciitis
  • Ga
    Date: 2014-04-03
    Interventions:
    • Drug: IVIG (Privigen) Three do
Completed Study Name: Exploratory Study of Raised Serum Lactate as a Marker of Necrotizing Fasciitis
Condition: Fasciitis, Necrotizing
Date: 2012-11-26